Stocks · Healthcare · Medical - Devices
Quanterix Corporation QTRX
$3.81 +4.67% Close, Oct 5, 2026 · NASDAQ · Market cap $171.5M
Strong growthHigh risk
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -86.2% from -72.4% a year earlier.
- The diluted share count rose 20.8% in a year.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 30%
- Revenue growth, 3-year CAGRBottom 48%
- Revenue growth accelerationTop 10%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 28%
- Gross marginBottom 28%
- Operating marginBottom 30%
- Accruals (lower is better)Top 21%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 10%
- Free-cash-flow yieldBottom 11%
- EBITDA / enterprise valueBottom 8%
- Sales / enterprise valueTop 11%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 6%
- 6-month returnBottom 47%
- 1-year return vs S&P 500Bottom 21%
- Distance from 52-week highBottom 20%
- Trend checklist (0–4)Top 43%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 16%
- Upside to consensus price targetBottom 3%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 4%
- Maximum drawdown, 3 yearsBottom 12%
- Beta vs S&P 500 (lower is better)Top 43%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 8.2% | 23.4% | ↑ |
| Gross margin | 55.1% | 42.6% | ↓ |
| Operating margin | -72.4% | -86.2% | ↓ |
| FCF margin | -26.5% | -48.2% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 23.4% | 8.2% | ↑ | Top 30% |
| Gross margin | 42.6% | 55.1% | ↓ | Bottom 28% |
| Operating margin | -86.2% | -72.4% | ↓ | Bottom 30% |
| Net margin | -80.3% | -56.7% | ↓ | — |
| Free-cash-flow margin | -48.2% | -26.5% | ↓ | — |
| Return on invested capital | -46.9% | — | Bottom 28% | |
| Revenue growth, 3-year CAGR | 9.5% | — | Bottom 48% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -15.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 8.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -28.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.04%
- Shareholder yield
- -0.04%
- Share count change, 1 year
- +20.8%
- Share count change, 3-year CAGR
- +7.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -3.9%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $3.00
- Target vs current price
- -21.3%
- Analysts with a rating
- 10
- Share rating Buy or Strong Buy
- 50%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | -153.5% | -40.0% | -35.7% | -33.3% | — |
| May 6, 2026 | -25.8% | -0.3% | -11.8% | +7.0% | +5.5% |
| Mar 2, 2026 | -40.7% | -3.4% | -22.7% | -45.3% | -59.1% |
| Nov 10, 2025 | -217.4% | +3.6% | +16.2% | +52.8% | +19.0% |
| Aug 7, 2025 | -87.8% | -1.8% | -14.6% | -23.0% | -10.9% |
| May 12, 2025 | +23.2% | +8.5% | -9.3% | -4.2% | +6.3% |
| Mar 17, 2025 | -11.1% | +3.1% | +2.3% | -26.3% | -6.8% |
| Nov 12, 2024 | +8.9% | -0.9% | -27.0% | -23.1% | -48.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$1.04 | -$0.41 | -153.5% | $32.9M |
| May 6, 2026 | -$0.39 | -$0.31 | -25.8% | $36.4M |
| Mar 2, 2026 | -$0.38 | -$0.27 | -40.7% | $43.9M |
| Nov 10, 2025 | -$0.73 | -$0.23 | -217.4% | $40.2M |
| Aug 7, 2025 | -$0.77 | -$0.41 | -87.8% | $24.5M |
| May 12, 2025 | -$0.53 | -$0.69 | +23.2% | $30.3M |
| Mar 17, 2025 | -$0.30 | -$0.27 | -11.1% | $34.1M |
| Nov 12, 2024 | -$0.22 | -$0.24 | +8.9% | $35.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1.05× | — | — | Top 11% |
| Free-cash-flow yield | -43.14% | — | — | Bottom 11% |
| Earnings yield | -69.03% | — | — | Bottom 10% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 10
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -10.9%
- 200-day average slope (20 days)
- -8.6%
- Distance from 50-day average
- +24.0%
- Distance from 200-day average
- -9.8%
- RSI (14)
- 66.5
- Relative volume
- 1.12×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 132.9%
- Volatility vs own 5-year history
- 93th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.99
- Correlation with S&P 500
- 0.19
- Current drawdown from 1-year high
- -52.7%
- Maximum drawdown, 3 years
- -91.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 19, 2021 | Aug 10, 2026 | -97.3% | 1373 days | Not yet recovered |
| Jan 21, 2021 | Jan 27, 2021 | -24.3% | 4 days | 11 days (Feb 11, 2021) |
| Oct 9, 2020 | Oct 30, 2020 | -20.7% | 15 days | 5 days (Nov 6, 2020) |
| Nov 13, 2020 | Nov 25, 2020 | -15.9% | 8 days | 30 days (Jan 11, 2021) |
| Nov 6, 2020 | Nov 9, 2020 | -13.8% | 1 days | 2 days (Nov 11, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $171.5M
- EPS, diluted (TTM)
- -$2.63
- Revenue (TTM)
- $153.3M
- 52-week range
- $2.15 – $8.77
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $110.6M | $105.5M | $121.1M | $135.4M | $138.7M |
| Gross profit | $64.8M | $45.4M | $73.0M | $81.1M | $64.7M |
| Operating income | -$56.5M | -$104.3M | -$46.0M | -$52.6M | -$109.8M |
| Net income | -$55.5M | -$99.6M | -$28.4M | -$38.5M | -$107.2M |
| EPS (diluted) | -$1.60 | -$2.61 | -$0.86 | -$1.00 | -$2.51 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.4M | $34.1M | $30.3M | $24.5M | $40.1M | $43.9M | $36.4M | $32.9M |
| Net income | -$8.4M | -$11.6M | -$20.5M | -$30.0M | -$33.5M | -$23.1M | -$17.5M | -$48.9M |
| EPS (diluted) | -$0.22 | -$0.30 | -$0.53 | -$0.77 | -$0.73 | -$0.49 | -$0.37 | -$1.04 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$47.9M | -$48.3M | -$18.9M | -$35.2M | -$77.2M |
| Capital expenditure | -$13.6M | -$11.7M | -$3.8M | -$3.4M | -$2.6M |
| Free cash flow | -$61.5M | -$60.0M | -$22.7M | -$38.5M | -$79.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $269.7M | $2.3M | $2.9M | $3.1M | $738,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $93.5M
- Total assets
- $319.6M
- Total liabilities
- $82.4M
- Total debt
- $33.4M
- Net debt
- -$10.8M
- Shareholders’ equity
- $237.2M
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 4,976,711
- Days to cover
- 4.23
- Change vs previous report
- +3.3%
FINRA short interest, settlement date Sep 15, 2026.